Intermittent malaria treatment as a component of the EPI (Expanded Programme on Immunization) schedule in Africa.
D000349:Africa / Q000453:epidemiology; D000740:Anemia / Q000209:etiology / Q000517:prevention & control; D000962:Antimalarials / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D004338:Drug Combinations; D006801:Humans; D017589:Immunization Programs / Q000458:organization & administration*; D007223:Infant; D008288:Malaria / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control*; D010865:Pilot Projects; D011739:Pyrimethamine / Q000008:administration & dosage*; D013413:Sulfadoxine / Q000008:administration & dosage*; D014944:World Health Organization
D000962:Antimalarials; D004338:Drug Combinations; C001205:fanasil, pyrimethamine drug combination; D013413:Sulfadoxine; D011739:Pyrimethamine